SMARCB1 Acts as a Quiescent Gatekeeper for Cell Cycle and Immune Response in Human Cells

被引:9
|
作者
Choi, Sung Kyung [1 ]
Kim, Myoung Jun [1 ]
You, Jueng Soo [1 ]
机构
[1] Konkuk Univ, Sch Med, Res Inst Med Sci, Dept Biochem, Seoul 05029, South Korea
基金
新加坡国家研究基金会;
关键词
SMARCB1; interleukin; 6; SWI-SNF; cell cycle; immune response; CHROMATIN REMODELING COMPLEXES; SWI/SNF COMPLEXES; ROLES; GENE; INTERLEUKIN-6; SUBUNIT; SYSTEM; LINE; SNF5; INI1;
D O I
10.3390/ijms21113969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Switch/sucrose non-fermentable (SWI/SNF)-related matrix-associated actin-dependent regulator of chromatin (SMARC) subfamily B member 1 (SMARCB1) is a core subunit of the switch/sucrose non-fermentable (SWI/SNF) complex, one of the adenosine triphosphate (ATP)-dependent chromatin remodeler complexes. The unique role of SMARCB1 has been reported in various cellular contexts. Here, we focused on the general role of the ubiquitous expression of SMARCB1 in a normal cell state. We selected ARPE19 (human primary retinal pigment epithelium) and IMR90 (from human fetal lung fibroblasts) cell lines as they have completely different contexts. Furthermore, although these cell lines have been immortalized, they are relatively close to normal human cells. The loss of SMARCB1 in ARPE19 and IMR90 cells reduced cell cycle progression via the upregulation of P21. Transcriptome analysis followed by SMARCB1 knockdown in both cell lines revealed that SMARCB1 was not only involved in cell maintenance but also conferred immunomodulation. Of note, SMARCB1 bound to interleukin (IL) 6 promoter in a steady state and dissociated in an active immune response state, suggesting that SMARCB1 was a direct repressor of IL6, which was further confirmed via loss- and gain-of-function studies. Taken together, we demonstrated that SMARCB1 is a critical gatekeeper molecule of the cell cycle and immune response.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Human Pluripotent Stem Cell Fate Regulation by SMARCB1
    Carmel-Gross, Ilana
    Levy, Etgar
    Armon, Leah
    Yaron, Orly
    Ben-Asher, Hiba Waldman
    Urbach, Achia
    STEM CELL REPORTS, 2020, 15 (05): : 1037 - 1046
  • [2] SMARCB1 regulates the hypoxic stress response in sickle cell trait
    Soeung, Melinda
    Perelli, Luigi
    Chen, Ziheng
    Dondossola, Eleonora
    Ho, -Lin
    Carbone, Federica
    Zhang, Li
    Khan, Hania
    Le, Courtney N.
    Zhu, Cihui
    Peoples, Michael D.
    Feng, Ningping
    Jiang, Shan
    Zacharias, Niki Millward
    Minelli, Rosalba
    Shapiro, Daniel D.
    Deem, Angela K.
    Gao, Sisi
    Cheng, Emily H.
    Lucchetti, Donatella
    Walker, Cheryl L.
    Carugo, Alessandro
    Giuliani, Virginia
    Heffernan, Timothy P.
    Viale, Andrea
    Tannir, Nizar M.
    Draetta, Giulio F.
    Msoue, Pavlo
    Genovese, Giannicola
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (21)
  • [3] Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter snp that alters PARP1 binding and SMARCB1 expression
    Pottier, Nicolas
    Cheok, Meyling H.
    Yang, Wenjian
    Assem, Mahfoud
    Tracey, Lorraine
    Obenauer, John C.
    Panetta, John C.
    Relling, Mary V.
    Evans, William E.
    HUMAN MOLECULAR GENETICS, 2007, 16 (19) : 2261 - 2271
  • [4] The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
    Wang, Yi-Wen
    Song, Hsiang-Lin
    Chiang, Cheng-Yao
    Song, Hong-Fang
    Chang, Hong-Yi
    Chu, Chien-An
    Tuan, Yih-Lin
    Tsai, Kun-Hao
    Ou, Yin-Chien
    Chow, Nan-Haw
    Tsai, Yuh-Shyan
    TRANSLATIONAL ONCOLOGY, 2021, 14 (10):
  • [5] A single-nucleotide polymorphism of SMARCB1 in human breast cancers
    Mimori, K
    Inoue, H
    Shiraishi, T
    Ueo, H
    Mafune, K
    Tanaka, Y
    Mori, M
    GENOMICS, 2002, 80 (03) : 254 - 258
  • [6] Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss
    Patel, Akshay J.
    Hemead, Hanan
    Jesani, Hannah
    Bille, Andrea
    Taniere, Philippe
    Middleton, Gary
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [7] Detection of SMARCB1 Loss in Ascites Cells in the Diagnosis of an Abdominal Rhabdoid Tumor
    Kerl, Kornelius
    Oyen, Florian
    Leuschner, Ivo
    Schneppenheim, Reinhard
    Nagel, Inga
    Siebert, Reiner
    Groll, Andreas H.
    Hartmann, Wolfgang
    Barth, Peter Josef
    Bartelheim, Kerstin
    Seringer, Angela
    Wardelmann, Eva
    Fruehwald, Michael C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 897 - 900
  • [8] Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
    Fischer, Anja
    Albert, Thomas K.
    Moreno, Natalia
    Interlandi, Marta
    Mormann, Jana
    Glaser, Selina
    Patil, Paurnima
    de Faria, Flavia W.
    Richter, Mathis
    Verma, Archana
    Balbach, Sebastian T.
    Wagener, Rabea
    Bens, Susanne
    Dahlum, Sonja
    Goebel, Carolin
    Muenter, Daniel
    Inserte, Clara
    Graf, Monika
    Kremer, Eva
    Melcher, Viktoria
    Di Stefano, Gioia
    Santi, Raffaella
    Chan, Alexander
    Dogan, Ahmet
    Bush, Jonathan
    Hasselblatt, Martin
    Cheng, Sylvia
    Spetalen, Signe
    Fossa, Alexander
    Hartmann, Wolfgang
    Herbrueggen, Heidi
    Robert, Stella
    Oyen, Florian
    Dugas, Martin
    Walter, Carolin
    Sandmann, Sarah
    Varghese, Julian
    Rossig, Claudia
    Schueller, Ulrich
    Tzankov, Alexandar
    Pedersen, Martin B.
    d'Amore, Francesco A.
    Mellgren, Karin
    Kontny, Udo
    Kancherla, Venkatesh
    Veloza, Luis
    Missiaglia, Edoardo
    Fataccioli, Virginie
    Gaulard, Philippe
    Burkhardt, Birgit
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [9] The mouse ortholog of the human SMARCB1 gene encodes two splice forms
    Bruder, CEG
    Dumanski, JP
    Kedra, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) : 886 - 890
  • [10] Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1
    Gupta, Sounak
    Swanson, Amy A.
    Erickson, Lori A.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (03) : 630 - 632